Compared with S/MP5− patients, S/MP5+ patients had larger tumor size (1.70 cm vs. 1.51 cm, p < 0.001), higher CTR (p < 0.001) and higher frequency of abnormal CEA (19.0% vs. 9.5%, p = 0.022). Here, CEACAM5 is linked to neoplasm.